SCHEMBL6640290

SCHEMBL6640290

CCOC(=O)CN(c1ccc2c(c1)nc(CNc1ccc(C(=N)N)cc1)n2C)S(=O)(=O)c1cccc2cccnc12

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 18/20 0.83
NQO2 P16083 2/20 0.57
SLC22A2 O15244 1/20 0.49
F10 P00742 1/20 0.49
PLG P00747 1/20 0.49
PLAT P00750 1/20 0.49
PROC P04070 1/20 0.49
HPN P05981 1/20 0.49
PRSS1 P07477 1/20 0.49
PRSS2 P07478 1/20 0.49
PRSS3 P35030 1/20 0.49
SLC47A2 Q86VL8 1/20 0.49
SLC47A1 Q96FL8 1/20 0.49
KLK1 P06870 1/20 0.46
KLK5 Q9Y337 1/20 0.46
NR1I2 O75469 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
SLC6A2 P23975 1/20 0.44
AGTR1 P30556 1/20 0.44
SLC6A3 Q01959 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6635608 0.95 F2 (0.81) F2NQO2SLC22A2F10PLG
SCHEMBL6632883 0.94 F2 (0.87) F2NQO2SLC22A2F10PLG
SCHEMBL6638945 0.91 F2 (0.70) F2NQO2SLC22A2F10PLG
SCHEMBL3000235 0.91 F2 (1.00) F2NQO2SLC22A2F10PLG
SCHEMBL6640782 0.90 F2 (0.70) F2NQO2SLC22A2F10PLG
Hydrochloric Acid SCHEMBL8016067 0.89 F2 (0.66) F2NQO2SLC22A2F10PLG
SCHEMBL6640152 0.89 F2 (0.83) F2NQO2F10PLG
Hydrochloric Acid SCHEMBL8017205 0.89 F2 (0.82) F2NQO2F10PLG
SCHEMBL6639091 0.89 F2 (0.84) F2NQO2
SCHEMBL6635592 0.89 F2 (0.66) F2NQO2SLC22A2F10PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100795-B1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2004-06-09 EP disclosed
EP-1100795-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM ZENTRALE GMBH (DE) 2001-05-23 EP disclosed
US-6121308-A INDOLE AND BENZIMIDAZOLE ANTITHROMBOTIC COMPOUNDS, SUCH AS 1-METHYL-2-(N-(4-AMIDINOPHENYL)-AMINOMETHYL)-5-(N-(HYDROXYCARBONYLMETHYL) -QUINOLINE-8-SULPHONYLAMINO)-INDOLE BOEHRINGER INGELHEIM KG (DE) 2000-09-19 US disclosed
WO-2000008014-A1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-02-17 WO disclosed